Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,120 | 13 | 97.9% |
| Food and Beverage | $493.84 | 11 | 1.2% |
| Travel and Lodging | $405.06 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $25,035 | 10 | $0 (2024) |
| Novo Nordisk Health Care AG | $10,710 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,052 | 8 | $0 (2019) |
| Global Blood Therapeutics, Inc. | $170.24 | 5 | $0 (2022) |
| CSL Behring | $28.83 | 1 | $0 (2017) |
| Novo Nordisk Inc | $23.19 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,047 | 6 | PFIZER INC. ($13,287) |
| 2023 | $17,698 | 6 | PFIZER INC. ($11,748) |
| 2022 | $18.05 | 1 | Global Blood Therapeutics, Inc. ($18.05) |
| 2021 | $139.74 | 3 | Global Blood Therapeutics, Inc. ($139.74) |
| 2020 | $12.45 | 1 | Global Blood Therapeutics, Inc. ($12.45) |
| 2019 | $169.27 | 3 | Novartis Pharmaceuticals Corporation ($146.08) |
| 2018 | $5,906 | 6 | Novartis Pharmaceuticals Corporation ($5,906) |
| 2017 | $28.83 | 1 | CSL Behring ($28.83) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,937.00 | General |
| 07/29/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,055.00 | General |
| 07/29/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,467.00 | General |
| 05/28/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,417.50 | General |
| 05/28/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,410.00 | General |
| 01/08/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $4,760.00 | General |
| 12/26/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $4,464.00 | General |
| 11/20/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,467.00 | General |
| 10/30/2023 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $5,950.00 | General |
| 09/28/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,527.00 | General |
| 08/28/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,115.00 | General |
| 05/22/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,175.00 | General |
| 02/15/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Sickle Cell Disease | ||||||
| 12/11/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $103.40 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 04/15/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 03/25/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/19/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/25/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 08/27/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $123.24 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2019 | Novo Nordisk Inc | Novoeight (Drug), REBINYN | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Hemophilia | ||||||
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Consulting Fee | Cash or cash equivalent | $5,375.00 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Travel and Lodging | In-kind items and services | $202.56 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Travel and Lodging | Cash or cash equivalent | $163.50 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Food and Beverage | In-kind items and services | $107.14 | General |
| 05/19/2018 | Novartis Pharmaceuticals Corporation | CRIZANLIZUMAB (Biological) | Travel and Lodging | Cash or cash equivalent | $39.00 | General |
About Dr. Betty Pace, MD
Dr. Betty Pace, MD is a Pediatric Hematology-Oncology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1700195039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Betty Pace, MD has received a total of $42,018 in payments from pharmaceutical and medical device companies, with $18,047 received in 2024. These payments were reported across 27 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($41,120).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Augusta, GA
- Active Since 10/05/2010
- Last Updated 10/05/2010
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1700195039
Products in Payments
- CRIZANLIZUMAB (Biological) $5,887
- OXBRYTA (Drug) $170.24
- PROMACTA (Drug) $141.60
- Afstyla (Biological) $28.83
- Novoeight (Drug) $23.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Augusta
Cindy Neunert, Md, MD
Pediatric Hematology-Oncology — Payments: $171,713
Dr. Claude Sportes, M.d, M.D
Pediatric Hematology-Oncology — Payments: $19,736
Nnenna Ukachi Badamosi, M.d, M.D
Pediatric Hematology-Oncology — Payments: $1,900
Dr. Theodore Johnson, M.d., Ph.d, M.D., PH.D
Pediatric Hematology-Oncology — Payments: $1,548
Afshin Ameri, Md, MD
Pediatric Hematology-Oncology — Payments: $1,454
Colleen Mcdonough, Md, MD
Pediatric Hematology-Oncology — Payments: $760.40